Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11460053 | PMC |
| http://dx.doi.org/10.1016/S2214-109X(24)00083-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dr. Soumya Swaminathan: A Pioneer in Global Health and Equity.
Cureus
November 2024
Emergency Medicine & Neurology, University of Central Florida, Orlando, USA.
Dr. Soumya Swaminathan, a renowned Indian physician and scientist, revolutionized medical practices through her significant contributions to tuberculosis and human immunodeficiency virus research, yielding a lasting impact on global health. As the former Chief Scientist of the World Health Organization, her committed approach to healthcare has been instrumental in linking scientific research and evidence to policy development.
View Article and Find Full Text PDFImpact of drug-resistant tuberculosis on socio-economic status, quality of life and psychological well-being of patients in Bucharest, Romania: a prospective cohort study.
J Health Popul Nutr
December 2024
Institute of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Background: Tuberculosis (TB) remains a global health challenge, with 1.3 million deaths in 2022. Ten countries in the European Union (EU) and European Economic Area (EEA) accounted for 88.
View Article and Find Full Text PDFTrends in tuberculosis and inequality-adjusted Human Development Index in Brazil, 2018-2022.
J Public Health Policy
December 2024
Department of Pathology, FMUSP, Av. Dr. Enéas de Carvalho Aguiar, 470, São Paulo, Brazil.
Tuberculosis (TB) remains a significant global health concern, causing 1.5 million deaths annually. We conducted an ecological analysis to examine TB prevalence in Brazil from 2018 to 2022, focusing on its relationship with the Human Development Index (HDI) and its inequality-adjusted version HDI (IHDI).
View Article and Find Full Text PDFPre-diagnosis and pre-treatment loss to follow-up and associated factors among patients with presumed tuberculosis and those diagnosed in Uganda.
BMC Health Serv Res
December 2024
School of Public Health, Department of Disease Control and Environmental Health, Makerere University, Kampala, Uganda.
Background: Loss to follow-up (LTFU) of patients with presumed tuberculosis (TB) before completing the diagnostic process (pre-diagnosis LTFU) and before initiating treatment for those diagnosed (pre-treatment LTFU) is a challenge in the realization of the End TB Strategy. We assessed the proportion of pre-diagnosis and pre-treatment LTFU and associated factors among patients with presumed TB and those diagnosed in the selected health facilities.
Methods: This was a retrospective cohort study involving a review of routinely collected data from presumptive, laboratory and TB treatment registers from January 2019 to December 2022.
Intradermal Versus Subcutaneous Immunization: Effects of Administration Route using a Lipid-PLGA Hybrid Nanoparticle Tuberculosis Vaccine.
Eur J Pharm Sci
December 2024
Department of Infectious Diseases, LUCID, Leiden University Medical Center (LUMC), The Netherlands.
Tuberculosis (TB) remains a significant global health challenge, latently affecting around a quarter of the global population. The sole licensed TB vaccine, Mycobacterium bovis Bacillus Calmette-Guérin (BCG), shows variable efficacy, particularly among adolescents and adults, underscoring the pressing need for more effective vaccination strategies. The administration route is crucial for vaccine efficacy, and administration via the skin, being rich in immune cells, may offer advantages over conventional subcutaneous routes, which lack direct access to abundant antigen-presenting cells.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!